Fibrogenic cytokines in vulvar lichen sclerosus: An immunohistochemical study

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 42, Issue 3, 1997, Pages 161-165

  Carli, Paolo ^a   Moretti, Silvia ^b   Spallanzani, Adelina ^b   Berti, Emilio ^b   Cattaneo, Antonio ^b  

^a Clinica Dermatologica II   (Italy)

^b NONE

Author keywords

cytokines, immunohistochemistry; lichen sclerosus; vulvar diseases

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; PRIORITY JOURNAL; SKIN INFILTRATE;

ADULT; AGED; CYTOKINES; EPIDERMIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-6; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; MIDDLE AGED; SKIN; TRANSFORMING GROWTH FACTOR BETA; VULVAR DISEASES;

EID: 0030894988     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Meffert JJ, Davis BM, Grimwood RE: Lichen sclerosus. J Am Acad Dermatol 1995;32:393-416
2. Patterson JAK, Ackerman AB: Lichen sclerosus et atrophicus is not related to morphea. Am J Dermatopathol 1984;6: 323-335
3. Natarajan S, Green ST: Generalized morphoea, lichen sclerosus et atrophicus, and primary biliary cirrhosis. Clin Exp Dermatol 1986;11:304-308
4. Uitto J, Santa Cruz DJ, Bauer EA, et al: Morphea and lichen sclerosus et atrophicus. J Am Acad Dermatol 1980;3:271-279
5. Gahan E: Hallopeau's communications on lichen sclerosus et atrophicus. Arch Dermatol Syphilol 1954;69:435-437
6. Schamberg JF, Hirschler R: Lichen planus sclerosus. JAMA 1909;53:369-373
7. Carli P, Cattaneo A, Pimpinelli N, et al: Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991;182:18-22
8. Carli P, Bracco GL, Taddei GL, et al: Vulvar lichen sclerosus: Immunohistologic evaluation before and after therapy. J Reprod Med 1994;39:110-114
9. Oikarinen A, Sandberg M, Hurskainen T, et al: Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques. Acta Derm Venereol (Stockh) (suppl) 1991;162:3-12
10. Gruschwitz M, Muller PU, Sepp N, et al: Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: A mediator of fibrosis? J Invest Dermatol 1990;94:197-203
11. Wahl SM, Wahl LM, McCarthy JB: Lymphocyte-mediated activation of fibroblast proliferation and collagen production. J Immunol 1978;121:942-946
12. Lever AF, Schaumburg-Lever G: Lichen sclerosus et atrophicus. In Histopathology of the Skin. Seventh edition. Philadelphia, JP Lippincott, 1990, pp 308-312
13. Dickie RJ, Home VHW, Sutherland HW, et al: Direct evidence of localized immunological damage in vulvar lichen sclerosus et atrophicus. J Clin Pathol 1982;35:1395-1397
14. Carli P, Cattaneo A: Skin immune system involvement as a clue to the pathogenesis of lichen sclerosus (lett). Eur J Dermatol 1994;4:572
15. Mauch C, Eckes B, Hunzelmann N, et al: Control of fibrosis in systemic scleroderma. J Invest Dermatol 1993;100:92S-96S
16. Sporn MB, Roberts AB: Transforming growth factor beta: Recent progress and new challenges. J Cell Biol 1992;119: 1017-1021
17. Maquart FX, Gillery P, Kalis B, et al: Cytokines and fibrosis. Eur J Dermatol 1994;2:91-97
18. Adelmann-Grill BC, Hein R, Wach F, et al: Inhibition of fibroblast chemotaxis by recombinant human interferon-gamma and interferon-alpha. J Cell Physiol 1987;130:270-275